Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,915
Closed -$924K 1071
2025
Q4
$924K Buy
13,915
+938
+7% +$60.6K 0.21% 167
2025
Q3
$873K Buy
+12,977
New +$1.03M 0.33% 69
2023
Q3
Sell
-1,600
Closed -$206K 503
2023
Q2
$206K Sell
1,600
-3,896
-71% -$471K 0.25% 199
2023
Q1
$639K Buy
+5,496
New +$615K 0.25% 123

Other funds holding DXCM

AXQ Capital's DXCM Position: Q1 2026 in Review

AXQ Capital sold out of DexCom (DXCM) in Q1 2026, closing a stake of 13,915 shares — an estimated $924K sold.

AXQ Capital first reported a position in DXCM in Q1 2023 and held it in 4 quarters. The position peaked at $924K in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • AXQ Capital reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • AXQ Capital sold 13,915 DexCom shares in Q1 2026, an estimated $924K.
  • AXQ Capital first reported a position in DexCom in Q1 2023 and held it in 4 quarters.
  • AXQ Capital's DexCom position peaked at $924K in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.